Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee

NAUnknownINTERVENTIONAL
Enrollment

332

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

March 31, 2016

Conditions
Knee Osteoarthritis
Interventions
DEVICE

HYMOVIS

Intra-articular injection

DEVICE

Placebo

Intra-Articular Injection

Trial Locations (21)

16602

Blair Orphopedics, Altoona

27609

PMG Research of Raleigh, Raleigh

32132

Riverside Clinical Research, Edgewater

32174

Ormond Medical Arts, Ormond Beach

34652

Suncoast Clinical Research, New Port Richey

35216

Achieve Clinical Research, Birmingham

35235

Alabama Clinical Therapeutics, Brimingham

43213

Columbus Clinical Research, Columbus

45242

New Horizons, Cincinnati

48706

Great Lakes Research Group, Bay City

63042

Healthcare Research Network, Hazelwood

77055

West Houston Clinical Research, Houston

80110

Colorado Orthopedic Consultants, Englewood

85018

Elite Clinical Studies, Phoenix

85023

Arizona Research Center, Phoenix

91360

Westlake Medical, Thousand Oaks

92020

Triwest Research Associates, El Cajon

95608

Med Center, Carmichael

06708

Chase Medical, Waterbury

02111

Tufts Medical Center, Boston

08234

Fabio Orozco, Egg Harbor

Sponsors
All Listed Sponsors
lead

Fidia Farmaceutici s.p.a.

INDUSTRY